Marin Xavier, MD, presents on ‘Integrating new evidence into everyday practice’

In this session from the SOHO Insider Community Oncology series, Marin Xavier, MD, a hematologist and oncologist at Scripps Clinic in San Diego, discusses the EPCORE FL-1 trial, the InMind study, and other emerging data and second-line treatment options for patients with follicular lymphoma.

Host Dr. Loretta Nastoupil also discusses with Dr. Xavier how to navigate second-line regimens like monoclonal antibodies versus bispecific T-cell engagers and manage logistical and toxicity concerns in community settings.

Watch more from the Community Oncology series.